A MULTICENTER, 3-ARM, OPEN-LABEL, PHASE IIA CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF TANIBIRUMAB (VEGFR2 MAB), IN PATIENTS WITH RECURRENT GBM ASSESSED WITH K-TRANS AND INITIAL AREA UNDER THE GADOLINIUM CONCENTRATION-TIME CURVE (IAUGC)

Lawrence Cher; Anna Nowak; George Iatropoulos; Weon Sup Lee; Seon Young Lee; Sang Ryeol Shim; Jin San Yoo

A MULTICENTER, 3-ARM, OPEN-LABEL, PHASE IIA CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF TANIBIRUMAB (VEGFR2 MAB), IN PATIENTS WITH RECURRENT GBM ASSESSED WITH K-TRANS AND INITIAL AREA UNDER THE GADOLINIUM CONCENTRATION-TIME CURVE (IAUGC)

Lawrence Cher, Anna Nowak, George Iatropoulos, Weon Sup Lee, Seon Young Lee, Sang Ryeol Shim, Jin San Yoo

UWA Medical School

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

6 Citations (Web of Science)

Original language	English
Pages (from-to)	17-17
Number of pages	1
Journal	Neuro-Oncology
Volume	19
Publication status	Published - Nov 2017
Event	22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology - San Francisco, United States Duration: 16 Nov 2017 → 19 Nov 2017

Cite this

@article{9e4d9dfb96f2465486a12ce7c2ff1e2a,

title = "A MULTICENTER, 3-ARM, OPEN-LABEL, PHASE IIA CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF TANIBIRUMAB (VEGFR2 MAB), IN PATIENTS WITH RECURRENT GBM ASSESSED WITH K-TRANS AND INITIAL AREA UNDER THE GADOLINIUM CONCENTRATION-TIME CURVE (IAUGC)",

author = "Lawrence Cher and Anna Nowak and George Iatropoulos and Lee, {Weon Sup} and Lee, {Seon Young} and Shim, {Sang Ryeol} and Yoo, {Jin San}",

year = "2017",

month = nov,

language = "English",

volume = "19",

pages = "17--17",

journal = "Neuro-Oncology",

issn = "1522-8517",

publisher = "Oxford University Press",

note = "22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology ; Conference date: 16-11-2017 Through 19-11-2017",

}

A MULTICENTER, 3-ARM, OPEN-LABEL, PHASE IIA CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF TANIBIRUMAB (VEGFR2 MAB), IN PATIENTS WITH RECURRENT GBM ASSESSED WITH K-TRANS AND INITIAL AREA UNDER THE GADOLINIUM CONCENTRATION-TIME CURVE (IAUGC). / Cher, Lawrence; Nowak, Anna; Iatropoulos, George et al.
In: Neuro-Oncology, Vol. 19, 11.2017, p. 17-17.

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

TY - JOUR

T1 - A MULTICENTER, 3-ARM, OPEN-LABEL, PHASE IIA CLINICAL TRIAL TO EVALUATE SAFETY AND EFFICACY OF TANIBIRUMAB (VEGFR2 MAB), IN PATIENTS WITH RECURRENT GBM ASSESSED WITH K-TRANS AND INITIAL AREA UNDER THE GADOLINIUM CONCENTRATION-TIME CURVE (IAUGC)

AU - Cher, Lawrence

AU - Nowak, Anna

AU - Iatropoulos, George

AU - Lee, Weon Sup

AU - Lee, Seon Young

AU - Shim, Sang Ryeol

AU - Yoo, Jin San

PY - 2017/11

Y1 - 2017/11

M3 - Abstract/Meeting Abstract

SN - 1522-8517

VL - 19

SP - 17

EP - 17

JO - Neuro-Oncology

JF - Neuro-Oncology

T2 - 22nd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology

Y2 - 16 November 2017 through 19 November 2017

ER -